Biomea Fusion (BMEA) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T17:50:48.407Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:50:48.407Z.

Quote observation: 2026-10-06T17:50:03.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -57,524,000
Quote market capitalization: 90,374,250
Total debt · period ending 2026-06-30: 877,000
Cash · period ending 2026-06-30: 34,824,000

FMP input reference: ee881eee59918e8cff759d9372c22030baed04f147f6b571d3011c58a892a573

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

BMEA EBITDA Yield Metrics

EBITDA YIELD

N/A

BMEA Competitors' EBITDA Yield

BMEA

Biomea Fusion, Inc.

Current

Market Cap

$90.37M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EQ

Equillium, Inc.

vs BMEA

Market Cap

$90.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLYB

Rallybio Corporation

vs BMEA

Market Cap

$90.32M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ECOR

electroCore, Inc.

vs BMEA

Market Cap

$89.53M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PMVP

PMV Pharmaceuticals, Inc.

vs BMEA

Market Cap

$89.33M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCC

ImmuCell Corporation

vs BMEA

Market Cap

$88.21M

EBITDA Yield

6.81%

TTM Avg

6.57%

3Y Avg

5.72%

5Y Avg

4.64%

PARK

Park Dental Partners, Inc. Common Stock

vs BMEA

Market Cap

$93.01M

EBITDA Yield

N/A

TTM Avg

2.46%

3Y Avg

2.46%

5Y Avg

2.46%

NMRA

Neumora Therapeutics, Inc. Common Stock

vs BMEA

Market Cap

$88.21M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CCLD

CareCloud, Inc.

vs BMEA

Market Cap

$88.60M

EBITDA Yield

21.29%

TTM Avg

23.06%

3Y Avg

41.09%

5Y Avg

38.38%

ATRA

Atara Biotherapeutics, Inc.

vs BMEA

Market Cap

$86.50M

EBITDA Yield

N/A

TTM Avg

17.90%

3Y Avg

17.90%

5Y Avg

17.90%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Biomea Fusion, Inc. (BMEA)	$90.37M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$90.73M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.32M	N/A	N/A	N/A	N/A
electroCore, Inc. (ECOR)vs ›	$89.53M	N/A	N/A	N/A	N/A
PMV Pharmaceuticals, Inc. (PMVP)vs ›	$89.33M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$88.21M	6.81%	6.57%	5.72%	4.64%
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$93.01M	N/A	2.46%	2.46%	2.46%
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$88.21M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$88.60M	21.29%	23.06%	41.09%	38.38%
Atara Biotherapeutics, Inc. (ATRA)vs ›	$86.50M	N/A	17.90%	17.90%	17.90%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

BMEA EBITDA Yield Metrics

BMEA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics